echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Professor Li Yan's research group has made new progress in the field of rapid quality evaluation of antibody drugs

    Professor Li Yan's research group has made new progress in the field of rapid quality evaluation of antibody drugs

    • Last Update: 2022-11-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    Recently, Professor Li Yan's research group from the Department of Pharmaceutical Analysis of the School of Pharmacy of Fudan University published a report entitled "Tractable Method for Rapid Quality Assessment of Therapeutic Antibodies in Harvested Cell Culture Fluid based on" in Analytical Chemistry, an authoritative journal in the field of pharmaceutical analysis FcγRIIIa-Immobilized Magnetic Microspheres"
    .
    This study establishes a new method
    for rapid quality evaluation of ADCC-enhanced antibody drugs in samples of engineered cell fermentation broth.

    Antibody drugs have become the fastest growing segment of
    biotechnology drugs in the world.
    Through molecular design and bioengineering, the affinity between antibody molecules and FcγRIIIa receptors on the surface of immune cells can be purposefully improved, and a new generation of antibody drugs
    with stronger "antibody-dependent cell-mediated cytotoxicity" (ADCC) effect and better tumor killing effect can be obtained.
    However, the traditional quality evaluation scheme for this class of antibody drugs needs to detect multiple key quality attributes including antibody-Fc receptor affinity one by one, which has problems such as
    cumbersome operation and long analysis time.

    The research team synthesized a FcγRIIIa protein-modified magnetic nanomaterial (Fe3O4@PDA@PAMAM-FcγRIIIa) with simultaneous coating of polydopamine and dendritic macromolecule PAMAM and applied it as a magnetosolid phase extraction adsorbent for rapid quality evaluation
    of engineered cell fermentation broth.

    Figure 1.
    Workflow of a new method for rapid quality evaluation of antibody drugs

    The new Fe3O4@PDA@PAMAM-Fc γRIIIa material can be directly added to the unpurified engineering cell fermentation broth, selectively binds to ADCC-enhanced antibody components with high affinity, and separates the material from the fermentation broth matrix by applying a magnetic field, which can easily and quickly achieve selective extraction and purification
    of high-affinity antibodies 。 The high-affinity antibody eluted from the surface of the material can then be directly analyzed by molecular exclusion chromatography (SEC), and the multi-dimensional key quality attribute information
    such as the affinity of the antibody-Fc receptor, the expression of high-affinity antibody and the degree of antibody aggregation in the original fermentation broth sample can be obtained at the same time through the target main peak area and main peak ratio on the chromatogram.
    By directly sorting the main peak area, the quality order of antibody drugs in the original fermentation broth sample can be obtained, and then the fermentation broth samples of the antibody drugs with the best quality expression can be quickly screened to guide the subsequent process development
    .
    This method can complete multi-dimensional quality data detection using only ordinary HPLC, and the operation steps are shortened to less than 20% of the traditional method, and the analysis time is shortened to less than
    16% of the traditional method.

    Feng Jianan, a 2020 doctoral student at the School of Pharmacy of Fudan University, is the first author of this paper; Professor Li Yan of the School of Pharmacy, Fudan University, is the corresponding author
    of this article.
    This work was supported
    by the National Natural Science Foundation of China.

    Original link: https://pubs.
    acs.
    org/doi/10.
    1021/acs.
    analchem.
    2c01350


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.